Analyst Price Targets — OSCR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 12, 2026 9:37 am | — | Raymond James | $18.00 | $13.60 | TheFly | Oscar Health upgraded to Outperform from Market Perform at Raymond James |
| February 11, 2026 1:55 pm | Jonathan Yong | UBS | $15.00 | $13.56 | TheFly | Oscar Health price target lowered to $15 from $17 at UBS |
| January 9, 2026 10:24 am | — | UBS | $17.00 | $16.90 | TheFly | Oscar Health upgraded to Neutral from Sell at UBS |
| January 5, 2026 10:28 am | Andrew Mok | Barclays | $18.00 | $14.97 | TheFly | Oscar Health upgraded to Equal Weight from Underweight at Barclays |
| October 14, 2025 8:58 am | — | Goldman Sachs | $17.00 | $20.40 | TheFly | Oscar Health initiated with a Neutral at Goldman Sachs |
| October 7, 2025 10:50 am | — | Wells Fargo | $14.00 | $22.31 | TheFly | Oscar Health price target raised to $14 from $10 at Wells Fargo |
| August 14, 2025 12:44 pm | Jessica Tassan | Piper Sandler | $13.00 | $14.64 | TheFly | Oscar Health price target lowered to $13 from $14 at Piper Sandler |
| August 8, 2024 8:17 am | Jessica Tassan | Piper Sandler | $28.00 | $18.38 | StreetInsider | Oscar Health Inc (OSCR) PT Raised to $28 at Piper Sandler |
| June 25, 2024 4:03 pm | Jessica Tassan | Piper Sandler | $25.00 | $17.64 | StreetInsider | Piper Sandler Starts Oscar Health Inc (OSCR) at Overweight |
| June 12, 2024 6:18 am | Stephen Baxter | Wells Fargo | $27.00 | $20.01 | TheFly | Oscar Health price target raised to $27 from $24 at Wells Fargo |
Latest News for OSCR
Zacks.com users have recently been watching Oscar Health (OSCR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Oscar Health (OSCR) stock has declined by 21.7% in under a month, from $15.70 on January 26, 2026, to $12.30 currently. Should you consider purchasing this dip?
Raiffeisen Bank International AG acquired a new stake in shares of Oscar Health, Inc. (NYSE: OSCR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 61,881 shares of the company's stock, valued at approximately $1,171,000. Other hedge funds and other institutional investors
Health insurance stocks have been beaten down over the last year. Oscar Health is a disruptive health insurer set for a profit rebound this year.
Oscar Health (OSCR) leverages technology to drive operational efficiency and profitability in a challenging health insurance environment. Despite industry headwinds, OSCR's individual member retention remains strong, supporting optimism for revenue growth and market share gains. 2026 guidance targets $18.7–$19.0B revenue, 82.4–83.4% MLR, 15.8–16.3% SG&A, and $250–$450M operating earnings, implying significant…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OSCR.
U.S. House Trading
No House trades found for OSCR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.